# FDA Warning Letter: Cosmetic Specialty Labs, Inc.
> 2024-03-05 · Division of Pharmaceutical Quality Operations II · `adb44ba3a664883f`
## Letter
- **Company:** Cosmetic Specialty Labs, Inc.
- **Posted Date:** 2024-03-05
- **Letter Issue Date:** 2024-02-29
- **Issuing Office:** Division of Pharmaceutical Quality Operations II
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*